GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Science Inc (XKRX:343090) » Definitions » Accounts Payable & Accrued Expense

HLB Science (XKRX:343090) Accounts Payable & Accrued Expense : ₩267.77 Mil (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is HLB Science Accounts Payable & Accrued Expense?

HLB Science's quarterly accounts payable & accrued expense declined from Dec. 2022 (₩1,138.86 Mil) to Dec. 2023 (₩356.95 Mil) and declined from Dec. 2023 (₩356.95 Mil) to Dec. 2024 (₩267.77 Mil).

HLB Science's annual accounts payable & accrued expense declined from Dec. 2022 (₩1,138.86 Mil) to Dec. 2023 (₩356.95 Mil) and declined from Dec. 2023 (₩356.95 Mil) to Dec. 2024 (₩267.77 Mil).


HLB Science Accounts Payable & Accrued Expense Historical Data

The historical data trend for HLB Science's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Science Accounts Payable & Accrued Expense Chart

HLB Science Annual Data
Trend Dec22 Dec23 Dec24
Accounts Payable & Accrued Expense
1,138.86 356.95 267.77

HLB Science Semi-Annual Data
Dec22 Dec23 Dec24
Accounts Payable & Accrued Expense 1,138.86 356.95 267.77

HLB Science Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.


HLB Science Business Description

Industry
Traded in Other Exchanges
N/A
Address
66, Achasan-ro, 6th Floor, Seongdong-gu, Seoul, KOR
HLB Science Inc develops biological new drugs to treat infectious diseases. Its product pipelines includes DD-S052P, DD-A279, and DD-A514.

HLB Science Headlines

No Headlines